Warning: Declaration of MyAuthPlugin::initUser(&$user) should be compatible with AuthPlugin::initUser(&$user, $autocreate = false) in /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php on line 37

Warning: session_name(): Cannot change session name when session is active in /home/tig/www/aalf/www/wiki/includes/Setup.php on line 222

Warning: session_set_cookie_params(): Cannot change session cookie parameters when session is active in /home/tig/www/aalf/www/wiki/includes/GlobalFunctions.php on line 2446

Warning: session_cache_limiter(): Cannot change cache limiter when session is active in /home/tig/www/aalf/www/wiki/includes/GlobalFunctions.php on line 2451

Warning: Parameter 1 to MediaWiki_TIGAutoAuthenticate() expected to be a reference, value given in /home/tig/www/aalf/www/wiki/includes/Hooks.php on line 117

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/Feed.php on line 125

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/WebResponse.php on line 10

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/WebResponse.php on line 10

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/WebResponse.php on line 10

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/WebResponse.php on line 10

Warning: Cannot modify header information - headers already sent by (output started at /home/tig/www/aalf/www/wiki/extensions/DDNAuthPlugin.php:4) in /home/tig/www/aalf/www/wiki/includes/WebResponse.php on line 10
http://beta.aalf.org/wiki/index.php?action=history&feed=atom&title=MansonConway708 2026-11-01T10:49:45Z Revision history for this page on the wiki MediaWiki 1.13.3 http://beta.aalf.org/wiki/index.php?title=MansonConway708&diff=64155&oldid=prev 2012-04-23T23:00:13Z

<p>New page: The widely used Breast Cancer Drug Often have Serious Negative effects Sirih Merah is a [http://herbalhembing.blogspot.com/2012/04/obat-kanker.html obat kanker] that interferes with the a...</p> <p><b>New page</b></p><div>The widely used Breast Cancer Drug Often have Serious Negative effects<br /> <br /> Sirih Merah is a [http://herbalhembing.blogspot.com/2012/04/obat-kanker.html obat kanker] that interferes with the adventure of estrogen specially in the mammary glands of women. This has been used to treat and prevent Breast Cancer (BC) for the last 3 decades. BC cells needs estrogen to develop. Without estrogen these cells are deprived of their vital nutrition and may die. This principle is used when Sirih Merah drug was formulated. Sirih Merah binds with the estrogen receptors within the breast thereby depriving breast cancer cells of vital protein in estrogen. To put it in layman's terms imagine an auditorium with a finite number of seats and assume the auditorium manager gives advance information to the well behaved people and books their tickets. The auditorium gets filled with many of the good guys the unruly bad elements who come late are rarely getting a location inside. The show within the auditorium continues on without having trouble or untoward events. In this case the nice guys are classified as the molecules inside the Sirih Merah which bind to estrogen receptors and the bad elements will be the breast cancer cells. Using this method is also referred to as competitive antagonism.<br /> <br /> Sirih Merah is effective only in estrogen receptor positive BC cases. It doesn't work on progesterone receptor breast cancer and HER2/neu (Human Epidermal growth factor Receptor 2)BC. Even so the very good news is that almost 70% of all of the breast cancer cases are Estrogen receptor positive ones and this drug can very effectively [http://herbalhembing.blogspot.com/2012/04/obat-kanker.html obat kanker payudara] and even prevent rid of it upfront.<br /> <br /> But there is a primary catch and use of this drug is not with no cost. No very easy pinch the wallet so much although insurance won't cover it in some instances. Sirih Merah is off of the patent since 2002. It is now considered a generic drug. It's price has dropped drastically from the time that. Although Sirih Merah is very efficient it is not commonly prescribed as being a preventive medicine because of it's chronic adverse reactions. This drug is known to trigger uterine or endometrial cancer or [http://herbalhembing.blogspot.com/2012/04/obat-kanker.html kanker] in numerous women. Possibility of developing this kind of cancer is quadrupled after using Sirih Merah for just 2 years. American Cancer Society has listed Sirih Merah as a known carcinogen. In several women this drug is known to create a spurt in triglyceride levels and fatty liver syndrome. Obviously these aren't good for heart or liver.<br /> <br /> Sirih Merah could have adverse affect the central nervous. It may severely impair cognition and memory. Many of patients who're prescribed this drug experience a couple of drop in sexual drive and libido. As in case of any risky treatment an expense benefit assessment really needs to be made. Breast cancer is a serious and fatal disease. If Sirih Merah is assessed to be really valuable in a precise patient's case it needs to be used. There are well developed preventive and alleviating treatments for the inside effects because of Sirih Merah.</div>

MansonConway708